Caitlyn Miller
Co-Founder & Chief Executive Officer TwoStep Therapeutics
Caitlyn Miller, PhD, co-founder and CEO of TwoStep Therapeutics, is dedicated to the company’s mission of bringing innovative targeted therapies to patients. Dr. Miller received her PhD in Bioengineering from Stanford University in the labs of Dr. Carolyn Bertozzi and Dr. Jennifer Cochran. During her PhD and postdoctoral work, Dr. Miller played a pivotal role in advancing technology that is now integrated into TwoStep’s therapeutic pipeline. Dr. Miller then joined the Stanford Innovative Medicines Accelerator as an Entrepreneur-In-Residence, where she spearheaded the efforts to spin out TwoStep Therapeutics.
Seminars
Wednesday 22nd July 2026
Preclinical Evaluation & Optimization of a Multi-Specific Targeting Peptide for Radioligand Therapy
12:00 pm
- Scientific rationale for TwoStep Therapeutics’ multi-specific targeting agent (PIP) and how it enables broad applicability across solid tumors
- Comparing the data from a single vs multitargeted approach to highlight the rationale of multi-specific targeting
- Optimization of the PIP-Radio Conjugate for RLT: approach and learnings to improve biodistribution and tumor retention
